Suppr超能文献

应变弹性成像在慢性肝病患者肝纤维化评估及预后判断中的应用

Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases.

作者信息

Tajiri Kazuto, Kawai Kengo, Sugiyama Toshiro

机构信息

The Third Department of Internal Medicine, Toyama University Hospital, 2630 Sugitani, Toyama, 930-0194, Japan.

出版信息

J Gastroenterol. 2017 Jun;52(6):724-733. doi: 10.1007/s00535-016-1277-y. Epub 2016 Oct 27.

Abstract

BACKGROUND

Estimation of liver stiffness is essential in the treatment of liver diseases. Various procedures alternative to liver biopsy have been developed, and transient elastography using shear wave is an established method for evaluating liver stiffness and has been shown to be a prognostic indicator. In contrast, strain elastography (SE) has been applied to evaluate liver stiffness, however the significance remains uncertain.

METHODS

We retrospectively analyzed 598 patients who underwent SE to evaluate the ability of estimating liver stiffness and the prognosis. Elasticity index (EI) was evaluated as an indicator of liver stiffness in this study.

RESULTS

EI was increased as histological fibrosis advanced. EI was significantly different between mild fibrosis (F0-2) and advanced fibrosis (F3, 4). In contrast, EI was similar among those with different activity scores. EI showed better diagnostic performance in estimating advanced fibrosis than other serological markers and good reproducibility. Furthermore, EI was shown to be an independent prognostic factor in patients with chronic liver diseases and also with hepatocellular carcinoma (HCC) with advanced stage.

CONCLUSIONS

SE could estimate advanced liver fibrosis without influence of liver inflammation unlike other serological liver fibrosis markers. SE might be a prognostic factor in chronic liver diseases and HCC.

摘要

背景

肝脏硬度评估在肝脏疾病治疗中至关重要。已开发出多种替代肝活检的方法,使用剪切波的瞬时弹性成像技术是评估肝脏硬度的既定方法,且已被证明是一种预后指标。相比之下,应变弹性成像(SE)已应用于评估肝脏硬度,但其意义仍不确定。

方法

我们回顾性分析了598例行SE检查的患者,以评估其评估肝脏硬度和预后的能力。本研究中弹性指数(EI)被评估为肝脏硬度指标。

结果

随着组织学纤维化进展,EI升高。轻度纤维化(F0 - 2)和重度纤维化(F3、4)之间EI有显著差异。相比之下,不同活动评分的患者EI相似。EI在评估重度纤维化方面比其他血清学标志物具有更好的诊断性能和良好的可重复性。此外,EI被证明是慢性肝病患者以及晚期肝细胞癌(HCC)患者的独立预后因素。

结论

与其他血清学肝纤维化标志物不同,SE可在不受肝脏炎症影响的情况下评估重度肝纤维化。SE可能是慢性肝病和HCC的预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验